Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1784463-68-8

Post Buying Request

1784463-68-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1784463-68-8 Usage

General Description

Methyl 5-chlorothiazole-4-carboxylate is a chemical compound with the molecular formula C6H5ClNO2S. It is a chlorothiazole derivative with a methyl ester functional group and is commonly used in the synthesis of pharmaceuticals and agrochemicals. methyl 5-chlorothiazole-4-carboxylate has potential applications as a building block in organic synthesis for producing various drug molecules due to its high reactivity and versatility. Methyl 5-chlorothiazole-4-carboxylate is also known for its role as an intermediate in the preparation of diverse heterocyclic compounds, making it a valuable tool in the chemical industry for the development of new drugs and agricultural products.

Check Digit Verification of cas no

The CAS Registry Mumber 1784463-68-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,7,8,4,4,6 and 3 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1784463-68:
(9*1)+(8*7)+(7*8)+(6*4)+(5*4)+(4*6)+(3*3)+(2*6)+(1*8)=218
218 % 10 = 8
So 1784463-68-8 is a valid CAS Registry Number.

1784463-68-8Downstream Products

1784463-68-8Relevant articles and documents

2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS

-

, (2021/06/26)

2-(1H-lndole-3-carbonyl)-thiazole-4-carboxamide derivatives and the corresponding imidazole, oxazole and thiophene derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 27 to 32 and 59 to 219; examples 1 to 8; compounds 1-1 to 1-97; tables 1-a, 2 and 3).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1784463-68-8